DENTSPLY SIRONA Inc. (XRAY) Stake Decreased by Summit Securities Group LLC
Summit Securities Group LLC decreased its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 53.4% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,188 shares of the medical instruments supplier’s stock after selling 3,646 shares during the period. Summit Securities Group LLC’s holdings in DENTSPLY SIRONA were worth $207,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Korea Investment CORP raised its position in DENTSPLY SIRONA by 139.9% in the second quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock valued at $139,000 after buying an additional 1,251 shares during the period. Howard Hughes Medical Institute raised its position in DENTSPLY SIRONA by 134.9% in the first quarter. Howard Hughes Medical Institute now owns 2,751 shares of the medical instruments supplier’s stock valued at $172,000 after buying an additional 1,580 shares during the period. Penserra Capital Management LLC raised its position in DENTSPLY SIRONA by 9.5% in the first quarter. Penserra Capital Management LLC now owns 2,760 shares of the medical instruments supplier’s stock valued at $172,000 after buying an additional 240 shares during the period. Howland Capital Management LLC purchased a new position in DENTSPLY SIRONA during the first quarter valued at approximately $203,000. Finally, IBM Retirement Fund raised its position in DENTSPLY SIRONA by 29.9% in the second quarter. IBM Retirement Fund now owns 3,324 shares of the medical instruments supplier’s stock valued at $216,000 after buying an additional 766 shares during the period. Hedge funds and other institutional investors own 95.17% of the company’s stock.
Shares of DENTSPLY SIRONA Inc. (XRAY) opened at 55.33 on Friday. DENTSPLY SIRONA Inc. has a 52-week low of $54.49 and a 52-week high of $65.68. The stock’s market cap is $12.70 billion. The firm’s 50-day moving average is $62.91 and its 200 day moving average is $62.30.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.65. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The company had revenue of $992.70 million for the quarter, compared to analysts’ expectations of $1 billion. During the same quarter last year, the company earned $0.76 earnings per share. The firm’s revenue for the quarter was down 2.9% on a year-over-year basis. Analysts forecast that DENTSPLY SIRONA Inc. will post $2.73 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 29th will be issued a dividend of $0.0875 per share. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.35 dividend on an annualized basis and a yield of 0.63%. DENTSPLY SIRONA’s payout ratio is currently -10.09%.
ILLEGAL ACTIVITY NOTICE: This piece of content was published by Daily Political and is the sole property of of Daily Political. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of United States and international copyright laws. The correct version of this piece of content can be read at https://www.dailypolitical.com/2017/08/13/dentsply-sirona-inc-xray-stake-decreased-by-summit-securities-group-llc.html.
Several research analysts recently commented on the stock. Stifel Nicolaus reiterated a “buy” rating and set a $66.00 price objective (down previously from $70.00) on shares of DENTSPLY SIRONA in a research note on Thursday. UBS AG reiterated a “neutral” rating and set a $59.00 price objective (down previously from $62.00) on shares of DENTSPLY SIRONA in a research note on Thursday. Morgan Stanley boosted their price objective on shares of DENTSPLY SIRONA from $66.00 to $67.00 and gave the stock an “overweight” rating in a research note on Thursday. TheStreet lowered shares of DENTSPLY SIRONA from a “b” rating to a “c+” rating in a research note on Wednesday. Finally, BidaskClub lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Saturday, June 10th. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and nine have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $66.75.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.